http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113402174-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C03C4-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C03C12-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C03B32-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C03C4-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C03B32-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C03C12-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-10
filingDate 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113402174-B
titleOfInvention Preparation method and application of borosilicate bioactive glass containing bismuth
abstract The invention provides a preparation method and application of a bismuth-containing borosilicate bioactive glass, and belongs to the field of biomedical materials. Through the preparation method of the present invention, the borosilicate bioactive glass containing bismuth elemental microcrystals can be prepared, which can effectively improve the photothermal effect of the borosilicate bioactive glass, and at the same time retains the biological properties of the borosilicate bioactive glass. It has important application prospects in adjuvant therapy after bone tumor surgery and adjuvant therapy after melanoma surgery.
priorityDate 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155

Total number of triples: 34.